Higher Levels of Peripheral Th17 T CD4+ Cells Are Associated With Immunological Non Response in HIV-Infected Patients Under Effective ART

J Acquir Immune Defic Syndr. 2018 Apr 15;77(5):e45-e47. doi: 10.1097/QAI.0000000000001627.

Authors

Ilaria De Benedetto^{1

2}, Michela Masetti³, Massimiliano Fabbiani^{1

2}, Mara Biasin³, Antonio Muscatello^{1

2}, Nicola Squillace^{1

2}, Mario Clerici⁴, Daria Trabattoni³, Andrea Gori^{1

2}, Alessandra Bandera^{1

2}

Affiliations

¹ Infectious Diseases Unit, S. Gerardo Hospital, Monza, Italy.
² University of Milano-Bicocca, Milan, Italy.
³ Chair of Immunology, Department of Biomedical and Clinical Sciences "L. Sacco," University of Milan, Milan, Italy.
⁴ Department of Physiopathology Medical-Surgery and Transplantation, University of Milan and Don C. Gnocchi Foundation ONLUS, IRCCS, Milan, Italy.

PMID: 29315114
DOI: 10.1097/QAI.0000000000001627

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Anti-Retroviral Agents / therapeutic use*
Antiretroviral Therapy, Highly Active
Cross-Sectional Studies
Female
HIV Infections / drug therapy*
HIV Infections / pathology*
Humans
Lymphocyte Count*
Lymphocyte Subsets / immunology*
Male
Th17 Cells / immunology*
Treatment Outcome

Substances

Anti-Retroviral Agents